Centers for Disease Control and Prevention Board of Scientific Counselors, National Center for Injury Prevention and Control, (BSC, NCIPC), 55171-55172 [2018-23976]

Download as PDF Federal Register / Vol. 83, No. 213 / Friday, November 2, 2018 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), National Institute for Occupational Safety and Health (NIOSH) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting of the Advisory Board on Radiation and Worker Health (ABRWH). This meeting is open to the public, limited only by the space available. The meeting space accommodates approximately 150 people and the audio conference line has 150 ports for callers. The public is welcome to submit written comments in advance of the meeting, to the contact person below. Written comments received in advance of the meeting will be included in the official record of the meeting. The public is also welcome to listen to the meeting by joining the teleconference (information below). DATES: The meeting will be held on December 12, 2018 from 8:30 a.m. to 5:30 p.m., PST, and December 13, 2018, 8:15 a.m. to 2:30 p.m., PST. A public comment session will be held on December 12, 2018 at 5:30 p.m. and conclude at 6:30 p.m. or following the final call for public comment, whichever comes first. ADDRESSES: Crowne Plaza, 300 North Harbor Drive, Redondo Beach, California 90272; Phone: (310) 318– 8888, Fax: (310) 376–1930 and audio conference call via FTS Conferencing. The USA toll-free dial-in number is 1– 866–659–0537; the pass code is 9933701. Web conference by Skype: Meeting CONNECTION: https:// webconf.cdc.gov/zab6/yzdq02pl?sl=1. FOR FURTHER INFORMATION CONTACT: Theodore Katz, MPA, Designated Federal Officer, NIOSH, CDC, 1600 Clifton Road, Mailstop E–20, Atlanta, Georgia 30329, Telephone (513) 533– 6800, Toll Free 1 (800) CDC–INFO, Email ocas@cdc.gov. . SUPPLEMENTARY INFORMATION: Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the SUMMARY: VerDate Sep<11>2014 17:57 Nov 01, 2018 Jkt 247001 new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines which have been promulgated by the Department of Health and Human Services (HHS) as a final rule, advice on methods of dose reconstruction which have also been promulgated by HHS as a final rule, advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program, and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to the CDC. NIOSH implements this responsibility for CDC. The Advisory Board’s charter was issued on August 3, 2001, renewed at appropriate intervals, rechartered under Executive Order 13811 on February 12, 2018, and will terminate on September 30, 2019. Purpose: This Advisory Board is charged with (a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advising the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. Matters to be Considered: The agenda will include discussions on the following: NIOSH Program Update; Department of Labor Program Update; Department of Energy Program Update; SEC Petitions Update; possible discussion of a site profile review (dose reconstruction methods) for Carborundum Company (Niagara Falls, New York); SEC Petitions for: Y–12 Plant (Oak Ridge, Tennessee), Metals and Controls Corporation (Attleboro, Massachusetts, Area IV Santa Susanna Field Laboratory (Ventura County, California), DeSoto Avenue Facility (Los Angeles, California), Superior Steel Company (Carnegie, Pennsylvania), and Los Alamos National Laboratory (Los Alamos, New Mexico); and a Board Work Session. Agenda items are subject to change as priorities dictate. The Chief Operating Officer, Centers for Disease Control and Prevention, has PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 55171 been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri A. Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2018–23975 Filed 11–1–18; 8:45 am] BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Board of Scientific Counselors, National Center for Injury Prevention and Control, (BSC, NCIPC) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Board of Scientific Counselors, National Center for Injury Prevention and Control, (BSC, NCIPC). This meeting is open to the public limited only by the space and ports available. The meeting room accommodates 70 participants and there will be 75 ports available. Due to the limited availability of phone line ports, we are encouraging the pubic to please register using the link provided: Register Here. There will be a public comment period at the end of the day from 03:30 p.m.—04:00 p.m. DATES: The meeting will be held on December 12, 2018, 09:00 a.m. to 04:30 p.m., EST. ADDRESSES: Center for Disease Control and Prevention, Chamblee Campus, Building 106, Conference Room 1–A, 4770 Buford Highway, Atlanta, Georgia 30341 and via Teleconference: Dial-In Number: 1–888–780–9652, Participant Code: 8435823. FOR FURTHER INFORMATION CONTACT: Gwendolyn H. Cattledge, Ph.D., M.S.E.H., Deputy Associate Director for Science, NCIPC, CDC, 4770 Buford Highway, NE, Mailstop F–63, Atlanta, GA 30341, Telephone (770) 488–1430. Email address: ncipcbsc@cdc.gov SUPPLEMENTARY INFORMATION: Purpose: The Board will: (1) Conduct, encourage, cooperate with, and assist other appropriate public health authorities, scientific institutions, and scientists in the conduct of research, investigations, experiments, demonstrations, and studies relating to SUMMARY: E:\FR\FM\02NON1.SGM 02NON1 55172 Federal Register / Vol. 83, No. 213 / Friday, November 2, 2018 / Notices the causes, diagnosis, treatment, control, and prevention of physical and mental diseases, and other impairments; (2) assist States and their political subdivisions in preventing and suppressing communicable and noncommunicable diseases and other preventable conditions and in promoting health and well-being; and (3) conduct and assist in research and control activities related to injury. The Board of Scientific Counselors makes recommendations regarding policies, strategies, objectives, and priorities; and reviews progress toward injury prevention goals and provides evidence in injury prevention-related research and programs. The Board also provides advice on the appropriate balance of intramural and extramural research, the structure, progress and performance of intramural programs. The Board is designed to provide guidance on extramural scientific program matters, including the: (1) Review of extramural research concepts for funding opportunity announcements; (2) conduct of Secondary Peer Review of extramural research grants, cooperative agreements, and contracts applications received in response to the funding opportunity announcements as it relates to the Center’s programmatic balance and mission; (3) submission of secondary review recommendations to the Center Director of applications to be considered for funding support; (4) review of research portfolios, and (5) review of program proposals. Matters to be Considered: The Board of Scientific Counselors will discuss science matters to include research strategies needed to guide the Center’s focus on reducing opioid overdose and to review the recommendations from the opioid prescribing for acute and chronic pain workgroup. Agenda items are subject to change as priorities dictate. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2018–23976 Filed 11–1–18; 8:45 am] BILLING CODE 4163–19–P VerDate Sep<11>2014 17:57 Nov 01, 2018 Jkt 247001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Council for the Elimination of Tuberculosis Meeting (ACET) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting of the Advisory Council for the Elimination of Tuberculosis Meeting (ACET). This meeting is open to the public, limited only by the space available. The meeting room accommodates approximately 80 people and has 100 ports for audio phone lines. Time will be available for public comment. The public is welcome to submit written comments in advance of the meeting. Comments should be submitted in writing by email to the contact person listed below. The deadline for receipt is Monday, December 10, 2018. Persons who desire to make an oral statement, may request it at the time of the public comment period on December 12, 2018 at 11:40 a.m., EST. DATES: The meeting will be held on December 11, 2018, 8:30 a.m. to 4:30 p.m., EST and December 12, 2018, 8:30 a.m. to 12:00 p.m., EST. ADDRESSES: 8 Corporate Blvd., Building 8, Conference Rooms 1–A/B/C, Atlanta, Georgia, 30329 and Web conference: 1– 877–927–1433 and participant passcode: 12016435 and https:// adobeconnect.cdc.gov/r5p8l2tytpq/. FOR FURTHER INFORMATION CONTACT: Margie Scott-Cseh, Committee Management Specialist, CDC, 1600 Clifton Road, NE, Mailstop: E–07, Atlanta, Georgia, 30333, telephone (404) 639–8317; zkr7@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: This Council advises and makes recommendations to the Secretary of Health and Human Services, the Assistant Secretary for Health, and the Director, CDC, regarding the elimination of tuberculosis. Specifically, the Council makes recommendations regarding policies, strategies, objectives, and priorities; addresses the development and application of new technologies; and reviews the extent to which progress has been made toward eliminating tuberculosis. Matters to be Considered: The agenda will include discussions on (1) Division SUMMARY: PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 of Tuberculosis Elimination (DTBE) funded Demonstration Project on Latent Tuberculosis Infection (LTBI) Testing and Treatment; (2) DTBE Communications Messaging and Campaigns; (3) Update on LTBI Treatment Guidelines; (4) Update on Drug Resistant Tuberculosis Guidelines; and (5) Update from ACET workgroups. Agenda items are subject to change as priorities dictate. The Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Sherri Berger, Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2018–23974 Filed 11–1–18; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS–3371–PN] Medicare and Medicaid Programs: Accreditation Commission for Health Care, Inc (ACHC) for Approval of its End Stage Renal Disease (ESRD) Facility Accreditation Program Centers for Medicare & Medicaid Services (CMS), HHS. ACTION: Notice with request for comment. AGENCY: This proposed notice acknowledges the receipt of an application from the Accreditation Commission for Health Care, Inc., for recognition as a national accrediting organization for End Stage Renal Disease Facilities that wish to participate in the Medicare or Medicaid programs. DATES: To be assured consideration, comments must be received at one of the addresses provided below, no later than 5 p.m. on December 3, 2018. ADDRESSES: In commenting, refer to file code CMS–3371–PN. Because of staff and resource limitations, we cannot accept comments by facsimile (FAX) transmission. Comments, including mass comment submissions, must be submitted in one of the following three ways (please choose only one of the ways listed): SUMMARY: E:\FR\FM\02NON1.SGM 02NON1

Agencies

[Federal Register Volume 83, Number 213 (Friday, November 2, 2018)]
[Notices]
[Pages 55171-55172]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-23976]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Centers for Disease Control and Prevention Board of Scientific 
Counselors, National Center for Injury Prevention and Control, (BSC, 
NCIPC)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Board of Scientific Counselors, 
National Center for Injury Prevention and Control, (BSC, NCIPC). This 
meeting is open to the public limited only by the space and ports 
available. The meeting room accommodates 70 participants and there will 
be 75 ports available. Due to the limited availability of phone line 
ports, we are encouraging the pubic to please register using the link 
provided: Register Here. There will be a public comment period at the 
end of the day from 03:30 p.m.--04:00 p.m.

DATES: The meeting will be held on December 12, 2018, 09:00 a.m. to 
04:30 p.m., EST.

ADDRESSES: Center for Disease Control and Prevention, Chamblee Campus, 
Building 106, Conference Room 1-A, 4770 Buford Highway, Atlanta, 
Georgia 30341 and via Teleconference: Dial-In Number: 1-888-780-9652, 
Participant Code: 8435823.

FOR FURTHER INFORMATION CONTACT: Gwendolyn H. Cattledge, Ph.D., 
M.S.E.H., Deputy Associate Director for Science, NCIPC, CDC, 4770 
Buford Highway, NE, Mailstop F-63, Atlanta, GA 30341, Telephone (770) 
488-1430. Email address: [email protected]

SUPPLEMENTARY INFORMATION: 
    Purpose: The Board will: (1) Conduct, encourage, cooperate with, 
and assist other appropriate public health authorities, scientific 
institutions, and scientists in the conduct of research, 
investigations, experiments, demonstrations, and studies relating to

[[Page 55172]]

the causes, diagnosis, treatment, control, and prevention of physical 
and mental diseases, and other impairments; (2) assist States and their 
political subdivisions in preventing and suppressing communicable and 
non-communicable diseases and other preventable conditions and in 
promoting health and well-being; and (3) conduct and assist in research 
and control activities related to injury. The Board of Scientific 
Counselors makes recommendations regarding policies, strategies, 
objectives, and priorities; and reviews progress toward injury 
prevention goals and provides evidence in injury prevention-related 
research and programs. The Board also provides advice on the 
appropriate balance of intramural and extramural research, the 
structure, progress and performance of intramural programs. The Board 
is designed to provide guidance on extramural scientific program 
matters, including the: (1) Review of extramural research concepts for 
funding opportunity announcements; (2) conduct of Secondary Peer Review 
of extramural research grants, cooperative agreements, and contracts 
applications received in response to the funding opportunity 
announcements as it relates to the Center's programmatic balance and 
mission; (3) submission of secondary review recommendations to the 
Center Director of applications to be considered for funding support; 
(4) review of research portfolios, and (5) review of program proposals.
    Matters to be Considered: The Board of Scientific Counselors will 
discuss science matters to include research strategies needed to guide 
the Center's focus on reducing opioid overdose and to review the 
recommendations from the opioid prescribing for acute and chronic pain 
workgroup. Agenda items are subject to change as priorities dictate.
    The Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Sherri Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2018-23976 Filed 11-1-18; 8:45 am]
 BILLING CODE 4163-19-P